Home
Conditions
Liver Diseases

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

8,379 public trials 1,304 recruiting studies

Refine in advanced search Browse all conditions

Liver Diseases trial results

Completed

Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Preserved Liver Function

NCT04522908

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: HELIOS Klinikum Bad Saarow Bad Saarow, Germany

Universitätsklinikum Köln AöR Cologne, Germany

BAG / Onkologische Gemeinschaftspraxis Dresden, Germany

Ev. Kliniken Essen-Mitte, Klinik für Internistische Onkologie Essen, Germany

View Trial Details

Completed

Ex-vivo Hypotermic Perfusion in Patients With Hepatocellular Carcinoma to Reduce the Incidence of Tumor Recurrence

NCT06720675

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

View Trial Details

Completed

Cabozantinib for Patients with Hepatocellular Carcinoma (HCC) Refractory to First Line Treatment

NCT04511455

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Helios Klinikum Bad Saarow Bad Saarow, Germany

Universitätsklinikum Köln Cologne, Germany

Universitätsklinikum Halle (Saale) Halle, Germany

Medizinische Hochschule Hannover Hanover, Germany

View Trial Details

Completed

Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers

NCT05431621

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +24 more
Locations: Xuhui Central Hospital, Shanghai Shanghai, Shanghai Municipality, China

Zhongshan Hospital of Fudan University Shanghai, Shanghai Municipality, China

Shanghai Public Health Clinical Center Shanghai, Shanghai Municipality, China

Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Validation of the TRAIN-AI for the Risk of HCC Recurrence After Liver Transplantation

NCT06799468

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
Locations: Not specified

View Trial Details

Completed

Effects of Berberine in Reducing Abdominal Visceral Adipose Tissue Among Individuals with Obesity and NAFLD

NCT05647915

Conditions: Body Weight, Digestive System Diseases, Fatty Liver, +11 more
Locations: Fuwai Hospital, Chinese Academy of Medical Sciences, National Center for Cardiovascular Diseases Beijing, China

View Trial Details

Completed

SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA

NCT05848947

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Inland Imaging Spokane, Washington, United States

View Trial Details

Completed

Zepatier in Patients with Substance Use

NCT04048850

Conditions: Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chemically-Induced Disorders, +25 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

View Trial Details

Completed

Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies

NCT05462314

Conditions: Biliary Cancer, Biliary Tract Diseases, Biliary Tract Neoplasms, +32 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Completed

A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD

NCT03744182

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: ProSciento Inc. Chula Vista, California, United States

View Trial Details

Liver Diseases

Liver Diseases trial results

Related conditions